Listing on the Nigerian Stock Exchange (NGX) provides companies with numerous benefits, including increased visibility, access to capital, and enhanced credibility.
However, not all companies choose to list due to regulatory requirements, the cost of compliance, and the need for transparency in financial reporting.
For those that do, market capitalization becomes a crucial indicator of their financial health and investor confidence.
In 2024, health companies listed on the NGX demonstrated their financial robustness through their market capitalizations.
This metric, which reflects the total market value of a company’s outstanding shares, provides insights into the company’s size, stability, and market presence.
Methodology
Nairametrics ranked the top health companies based on their market capitalization as of the end of July 2024, using the daily summary of the last day in July 2024, exploring their operations, histories, and positions in the market.
Market Capitalization: N10,196,140,000
May & Baker Nigeria Plc, established in 1944, is one of Nigeria’s oldest and most renowned pharmaceutical companies.
The company produces a wide array of pharmaceutical products, including antibiotics, antimalarials, and over-the-counter medications.
Headquartered in Lagos, May & Baker operates manufacturing plants and has a distribution network.
The company claims to have a reputation for quality, reliability and a strong position in the market.
By the end of July 2024, May & Baker’s market capitalization was N10,196,140,000, with shares trading at N5.91.
